{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:33:02Z","timestamp":1761514382435,"version":"3.41.2"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T00:00:00Z","timestamp":1556064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00768","type":"journal-article","created":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T01:00:00Z","timestamp":1556067600000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Impaired STAT3-Dependent Upregulation of IL2R\u03b1 in B Cells of a Patient With a STAT1 Gain-of-Function Mutation"],"prefix":"10.3389","volume":"10","author":[{"given":"Menno C.","family":"van Zelm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian J.","family":"Bosco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei M.","family":"Aui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"De Jong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"Hore-Lacy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robyn E.","family":"O'Hehir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert G.","family":"Stirling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul U.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,4,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1097\/ACI.0b013e328358cc0b","article-title":"Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis","volume":"12","author":"Puel","year":"2012","journal-title":"Curr Opin Allergy Clin Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1084\/jem.20110958","article-title":"Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis","volume":"208","author":"Liu","year":"2011","journal-title":"J Exp Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1182\/blood-2015-11-679902","article-title":"Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype","volume":"127","author":"Toubiana","year":"2016","journal-title":"Blood."},{"key":"B4","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1056\/NEJMoa1100102","article-title":"STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis","volume":"365","author":"van","year":"2011","journal-title":"N Engl J Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.gene.2016.04.006","article-title":"Common variable immunodeficiency, impaired neurological development and reduced numbers of T regulatory cells in a 10-year-old boy with a STAT1 gain-of-function mutation","volume":"586","author":"Kobbe","year":"2016","journal-title":"Gene."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1038\/leu.2012.122","article-title":"EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols","volume":"26","author":"Kalina","year":"2012","journal-title":"Leukemia."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/j.jaci.2017.07.024","article-title":"Expansion of blood IgG4(+) B, TH2, and regulatory T cells in patients with IgG4-related disease","volume":"141","author":"Heeringa","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1172\/JCI39748","article-title":"CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency","volume":"120","author":"van","year":"2010","journal-title":"J Clin Invest."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1172\/JCI37083","article-title":"A partial form of recessive STAT1 deficiency in humans","volume":"119","author":"Chapgier","year":"2009","journal-title":"J Clin Invest."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.4049\/jimmunol.1402708","article-title":"Circulating human CD27-IgA+ memory B cells recognize bacteria with polyreactive Igs","volume":"195","author":"Berkowska","year":"2015","journal-title":"J Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jim.2007.09.017","article-title":"Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning","volume":"329","author":"Tiller","year":"2008","journal-title":"J Immunol Methods."},{"key":"B12","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/icb.2017.43","article-title":"Human IgG2- and IgG4-expressing memory B cells display enhanced molecular and phenotypic signs of maturity and accumulate with age","volume":"95","author":"de","year":"2017","journal-title":"Immunol Cell Biol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.1182\/blood-2013-06-506865","article-title":"IL-21 signalling via STAT3 primes human naive B cells to respond to IL-2 to enhance their differentiation into plasmablasts","volume":"122","author":"Berglund","year":"2013","journal-title":"Blood."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1002\/eji.201445344","article-title":"Gain-of-function STAT1 mutations impair STAT3 activity in patients with chronic mucocutaneous candidiasis (CMC)","volume":"45","author":"Zheng","year":"2015","journal-title":"Eur J Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1469-0691.2011.03676.x","article-title":"Adjunctive immunotherapy with recombinant cytokines for the treatment of disseminated candidiasis","volume":"18","author":"van","year":"2012","journal-title":"Clin Microbiol Infect."},{"key":"B16","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3324\/haematol.2015.136630","article-title":"Impaired killing of Candida albicans by granulocytes mobilized for transfusion purposes: a role for granule components","volume":"101","author":"Gazendam","year":"2016","journal-title":"Haematologica."},{"key":"B17","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.imlet.2015.05.008","article-title":"Immunotherapy with G-CSF in patients with chronic mucocutaneous candidiasis","volume":"167","author":"van","year":"2015","journal-title":"Immunol Lett."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/j.jaci.2018.07.020","article-title":"Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations","volume":"142","author":"Forbes","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.jaci.2014.12.1867","article-title":"Use of ruxolitinib to successfully treat chronic mucocutaneous candidiasis caused by gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation","volume":"135","author":"Higgins","year":"2015","journal-title":"J Allergy Clin Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.jaci.2018.02.045","article-title":"Baricitinib treatment in a patient with a gain-of-function mutation in signal transducer and activator of transcription 1 (STAT1)","volume":"142","author":"Meesilpavikkai","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"ofx202","DOI":"10.1093\/ofid\/ofx202","article-title":"Risks of ruxolitinib in STAT1 gain-of-function-associated severe fungal disease","volume":"4","author":"Zimmerman","year":"2017","journal-title":"Open Forum Infect Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.rmed.2017.03.018","article-title":"Autosomal dominant gain of function STAT1 mutation and severe bronchiectasis","volume":"126","author":"Breuer","year":"2017","journal-title":"Respir Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.3349\/ymj.2018.59.8.1004","article-title":"Bronchiectasis and recurrent respiratory infections with a de novo STAT1 gain-of-function variant: first case in Korea","volume":"59","author":"Huh","year":"2018","journal-title":"Yonsei Med J."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00768\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T01:00:02Z","timestamp":1556067602000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00768\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,24]]},"references-count":23,"alternative-id":["10.3389\/fimmu.2019.00768"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00768","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2019,4,24]]},"article-number":"768"}}